Orthocare Innovations is a leading research and development company developing the latest in prosthetic and orthotic technologies. The company’s product development approach is to produce products that are consistent with, and contribute to, evidenced-based practice demands for verifiable clinical efficacy.
GET CONNECTED. STAY CONNECTED.
For people with prosthetic and orthotic devices who desire more, Orthocare Innovations designs and manufactures devices that seamlessly connect you to your world, your device and your clinician. Offering capabilities completely unique to the market, our proprietary technology automatically adapts to your every step for easy and graceful movement. Integrating mobile technology that delivers real-life activity data to your clinician, every device improves long-term prosthetic fit and comfort.
NO BOUNDARIES. NO LIMITATIONS.
Our devices “transcend boundaries,” our products move with you, requiring little effort on your part and supplementing your body’s natural intelligence. Employing breakthrough ideas, we’re designing a future where every prosthesis automatically adapts to the changing needs of the user, creating a world where all activity becomes second nature again.
Orthocare Innovations is a winner of many national engineering achievement awards including R&D 100 awards, the DaVinci Award and two Edison Awards.
Board of Directors
Peter serves as a Managing Director at Schooner Capital. He previously spent a decade with management consultancy McKinsey & Company. While there, Peter specialized in corporate finance and strategy, advising leading players in the consumer packaged goods and retail industries in the US, Latin America and Western Europe. Peter serves as a director on the boards of Orthocare Innovations, Modus Health, RailComm, and Colo. Peter holds a JD/MBA from Harvard Law and from Harvard Business School where he was a Baker scholar, and an AB with Honors from Harvard University where he graduated Phi Beta Kappa in Economics and Social Studies.
Dr. Boone has spent the past 20 years as an innovator, developer, researcher and instructor in rehabilitation and bioengineering. A frequent lecturer at academic medical centers on a range of prosthetic and rehabilitation topics, and a widely published author, he is credited with multiple technology patents, including a foot-scanning technology that was licensed to Nike. Recently, he was the inventor and lead developer of two new patent-pending alignment technologies: Compas™ and RoboPAL, supported by the National Institutes of Health.
Dr. Boone received his Ph.D. in Bioengineering from The Hong Kong Polytechnic University and became one of fewer than ten American Ph.D.s with formal training and clinical experience in prosthetics.
Ted has served as a Managing Director at Schooner Capital since 2004. Presently, Ted serves as a director at Eastern Point Capital, Orthocare Innovations, MediaSilo, Modus Health, Millstone Medical Outsourcing, Nanoscale Powders, Seventh Generation, SRS Medical, Topokine Therapeutics and Zixi. Ted is a cum laude graduate of Dartmouth College, majoring in Chinese language and culture. He received an MBA from Harvard Business School.
Doug McCormack is Co-Founder and Chairman of Orthocare Innovations, LLC. He also served as CEO from inception through closing of the Company’s significant strategic transaction with the global market leader in the industry. Mr. McCormack is also Founder, founding CEO and Chairman of Modus, LLC.
Prior to his work in launching and building startup companies, Mr. McCormack spent fifteen years in Washington D.C. in law, policy and police, culminating as a partner in a major national law firm that was a predecessor to what today is the largest law firm in the world.